<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">62886</id>
  <title nil="true"/>
  <common-name>4-[1-[[(E)-octadec-9-enoyl]amino]propan-2-yloxy]-4-oxo-2-sulfobutanoic acid</common-name>
  <description>4-[1-[[(E)-octadec-9-enoyl]amino]propan-2-yloxy]-4-oxo-2-sulfobutanoic acid belongs to the fatty acids and conjugates, a subclass of fatty acyls within the organic compounds. It has the formula C25H45N1O8S1. With an average molecular weight of 519.70 g/mol, 4-[1-[[(E)-octadec-9-enoyl]amino]propan-2-yloxy]-4-oxo-2-sulfobutanoic acid is a heavy molecule. It is classified within the superclass of lipids and lipid-like molecules.</description>
  <cas nil="true"/>
  <pubchem-id>6437275</pubchem-id>
  <chemical-formula>C25H45N1O8S1</chemical-formula>
  <weight>519.7</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-02T22:42:51Z</created-at>
  <updated-at type="dateTime">2026-08-31T04:47:38Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCCCCCCC/C=C/CCCCCCCC(=O)NCC(C)OC(=O)CC(C(=O)O)S(=O)(=O)O</moldb-smiles>
  <moldb-formula>C25H45N1O8S1</moldb-formula>
  <moldb-inchi>InChI=1S/C25H45NO8S/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)26-20-21(2)34-24(28)19-22(25(29)30)35(31,32)33/h10-11,21-22H,3-9,12-20H2,1-2H3,(H,26,27)(H,29,30)(H,31,32,33)/b11-10+</moldb-inchi>
  <moldb-inchikey>MGYNSFHFMQUQLF-ZHACJKMWSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">519.286588</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id>4941845</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM058779</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00013626</susdat-id>
  <iupac>4-[1-[[(E)-octadec-9-enoyl]amino]propan-2-yloxy]-4-oxo-2-sulfobutanoic acid</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Lipids and lipid-like molecules</superklass>
  <klass>Fatty Acyls</klass>
  <subklass>Fatty acids and conjugates</subklass>
  <paper-count type="integer">0</paper-count>
  <sync-id>CED0150341</sync-id>
  <structure-inchikey>MGYNSFHFMQUQLF-ZHACJKMWSA-N</structure-inchikey>
  <structure-fingerprint>400000200040000004008000000000000000000000000000040000000000000000000010020000000000000200000000040040000004000000000000400000000000000000000000000180020000000000200000000023000000000000000000010000200100000000080000000000000000000000000000000000000000000020000000c0000000000000000020010080000000000000000000000000001000002000000000000000080000002000000000000088000000080000000000040000000808000004000000000000000000000000000000020000000010000000000000000000000800000000000000010400000000000000000000000080800000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAIgAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:15:54Z</structure-indexed-at>
</compound>
